Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Tirzepatide moves more than half of treated teens below obesity threshold, new clinical trial reports

Tirzepatide (Zepbound) is a once-weekly injectable medication that hits two targets at once. This dual-action drug mimics the effects of two natural gut hormones in the body—glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1). Working together, these hormones keep blood sugar in check, slow the movement of food through the gut and signal the brain about…

Tirzepatide moves more than half of treated teens below obesity threshold, new clinical trial reports

We haven't written up this one. Medical Xpress has the full story — the link below goes straight to it.

Read the original at medicalxpress.com →

More in Health & Medicine

More from Tuesday 17 November →